Cholera Clinical Trials

66 clinical trials for Cholera across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cholera Control by Case-area Targeted Interventions (CATIs) — RECRUITING · NA
• Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7) — RECRUITING · NA
• Vaccine- and Infection-derived Correlates of Protection for Cholera — RECRUITING · NA
• Preventative Intervention for Cholera for 7 Days — RECRUITING · NA
• Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI) — RECRUITING · NA
• Impact Study of Cholera Vaccination in Endemic Areas - Clinical Surveillance — RECRUITING
• Single Dose Azithromycin to Prevent Cholera in Children — COMPLETED · PHASE2
• Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera — COMPLETED · PHASE2
• Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea — COMPLETED · PHASE2
• Immunologic Responses to a Live Attenuated Oral Cholera Vaccine — COMPLETED · PHASE2
• Simulation Based Training In Medical Students — COMPLETED · NA
• Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines — COMPLETED · PHASE4
• Impact Study of Cholera Vaccination in Endemic Areas - Seroprevalence — COMPLETED
• Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change — COMPLETED · NA
• Follow-up of Pregnant Women After a Mass Vaccination of Oral Cholera Vaccine (ShancholTM) in Nsanje Malawi — TERMINATED · NA
• Co-administration Study of OCV, TCV and MR — OTHER · PHASE3
• A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults — COMPLETED · PHASE3
• A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults — COMPLETED · PHASE3
• VAXCHORA Pediatric Study to Assess Safety and Immunogenicity — COMPLETED · PHASE4
• Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera — COMPLETED · PHASE3
• Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 — COMPLETED · PHASE1
• Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™ — COMPLETED · PHASE3
• Immune Response to a Delayed Second Dose of Oral Cholera Vaccine — OTHER · PHASE4
• To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131) — OTHER · PHASE3
• First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers — OTHER · PHASE1
• Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of Congo — COMPLETED · NA
• A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131). — OTHER · PHASE3
• Single Dose Ciprofloxacin in the Treatment of Childhood Cholera:Randomized Controlled Clinical Trial — COMPLETED · PHASE3
• Cholera-Hospital-Based-Intervention-for-7-days — COMPLETED · NA
• Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine — COMPLETED · PHASE4
• Cholera Anti-Secretory Treatment Trial — COMPLETED · PHASE2
• Immunogenicity of Cholera Vaccine in Children With IBD — COMPLETED · NA
• Cholera Vaccine Investment Strategy in Bangladesh — COMPLETED
• PXVX0200 (CVD103-HgR) vs Shanchol in Mali — COMPLETED · PHASE2
• Evaluation of a Pilot Program to Introduce Cholera Vaccine in Haiti as Part of Global Cholera Control Efforts — COMPLETED
• Immunity to Human Cholera in Bangladesh — COMPLETED
• Safety and Immunogenicity of Locally Manufactured New (HL-OCV) Oral Cholera Vaccine — COMPLETED · PHASE1
• A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic — COMPLETED · PHASE3
• A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines — COMPLETED · PHASE4
• Single Dose Oral Cholera Vaccine Study in Dhaka, Bangladesh — COMPLETED · PHASE3
• Safety and Immunogenicity of Locally Manufactured Oral Cholera Vaccine — COMPLETED · PHASE2
• Introduction of Cholera Vaccine in Bangladesh — COMPLETED · NA
• Safety and Immunogenicity of a New Formulation of Euvichol® — OTHER · PHASE3
• Oral Cholera Vaccine Delivery in Rural Bangladesh — COMPLETED · NA
• PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera — COMPLETED · PHASE1
• Bridging Study for Killed Oral Cholera Vaccine in Ethiopia — COMPLETED · PHASE4
• Safety and Immunogenicity of a Killed Oral Cholera Vaccine in Infants — OTHER · PHASE2
• Randomized Controlled Trial of Killed Oral Cholera Vaccine in Kolkata — COMPLETED · PHASE3
• A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED THREE-LOT CONSISITENCY STUDY IN HEALTHY ADULT VOLUNTEERS TO ASSESS IMMUNOGENICITY, AND CLINICAL ACCEPTABILITY OF A SINGLE-DOSE OF THE LIVE ORAL CHOLERA VACCINE CANDIDATE PXVX0200, VIBRIO CHOLERAE O1 SEROTYPE INABA VACCINE STRAIN CVD 103-HGR — NOT_YET_RECRUITING · PHASE3
• Study of Alternative Vaccination Schedule of Oral Cholera Vaccine — COMPLETED · PHASE2

Refine this search